Adler, Amanda
Churchill Hospital · Oxford Centre for Diabetes, Endocrinology and Metabolism
16 papers on CoChatORCID 0000-0002-2797-3385
Most cited papers
- Verified
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
Adler, A. I. (2000) · BMJ
Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 2,133
- Verified
The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)
STEVENS, R. J., KOTHARI, V., ADLER, A. I., & STRATTON, I. M. (2001) · Clinical Science
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 1,084
- Verified
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
Rahimi, K., Bidel, Z., Nazarzadeh, M., Copland, E., Canoy, D., Ramakrishnan, R., Pinho-Gomes, A.-C., Woodward, M., Adler, A., Agodoa, L., et al. (2021) · The Lancet
Blood Pressure and Hypertension StudiesSodium Intake and Health
Cited by 1,074
- Verified
Risk Factors for Renal Dysfunction in Type 2 Diabetes
Retnakaran, R., Cull, C. A., Thorne, K. I., Adler, A. I., Holman, R. R., & for the UKPDS Study Group (2006) · Diabetes
Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 927
- Verified
UKPDS 59: Hyperglycemia and Other Potentially Modifiable Risk Factors for Peripheral Vascular Disease in Type 2 Diabetes
Adler, A. I., Stevens, R. J., Neil, A., Stratton, I. M., Boulton, A. J. M., Holman, R. R., & for the U.K. Prospective Diabetes Study Group (2002) · Diabetes Care
Peripheral Artery Disease ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 429
- Verified
Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes
Molitch, M. E., Adler, A. I., Flyvbjerg, A., Nelson, R. G., So, W.-Y., Wanner, C., Kasiske, B. L., Wheeler, D. C., de Zeeuw, D., & Mogensen, C. E. (2015) · Kidney International
Chronic Kidney Disease and DiabetesAcute Kidney Injury Research
Cited by 268
- Verified
Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
Adler, A. I., Coleman, R. L., Leal, J., Whiteley, W. N., Clarke, P., & Holman, R. R. (2024) · The Lancet
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 166
- Verified
Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis
Erqou, S., Lee, C. C., & Adler, A. I. (2014) · Diabetologia
Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 126
- Verified
Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51)
Clarke, P., Gray, A., Adler, A., Stevens, R., Raikou, M., Cull, C., Stratton, I., & Holman, R. (2001) · Diabetologia
Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and Management
Cited by 99
- Verified
Economic evaluation of type 2 diabetes prevention programmes: Markov model of low- and high-intensity lifestyle programmes and metformin in participants with different categories of intermediate hyperglycaemia
Roberts, S., Craig, D., Adler, A., McPherson, K., & Greenhalgh, T. (2018) · BMC Medicine
Health Systems, Economic Evaluations, Quality of LifeDiabetes Treatment and Management
Cited by 48
- VerifiedRetracted
WITHDRAWN: Reprint of: Classification of diabetes mellitus
Adler, A., Bennett, P., Chair, S. C., Gregg, E., Venkat Narayan, K. M., Schmidt, M. I., Sobngwi, E., Tajima, N., Tandon, N., Unwin, N., et al. (2021) · Diabetes Research and Clinical Practice
Diabetes Management and ResearchDiabetes and associated disorders
Cited by 38
- Verified
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
Gillessen, S., Murphy, L., James, N. D., Sachdeva, A., El-Taji, O., Abdel-Aty, H., Adler, A. I., Amos, C., Attard, G., Varughese, M., et al. (2025) · The Lancet Oncology
Metabolism, Diabetes, and CancerProstate Cancer Treatment and Research
Cited by 28
- Verified
Diabetes Associated With Atypical Antipsychotic Treatment may Be Severe But Reversible: Case Report
Dibben, C. R. M., Kalavalapalli, S. S., Linnington, H. E. J., Hynes, F. A., Dinneen, S. F., Adler, A. I., & McKenna, P. J. (2005) · The International Journal of Psychiatry in Medicine
Schizophrenia research and treatmentElectroconvulsive Therapy Studies
Cited by 21
- Verified
Inactivation of genes in oxidative respiration and iron acquisition pathways in pediatric clinical isolates of small-colony variant Enterobactericeae
Greninger, A. L., Addetia, A., Tao, Y., Adler, A., & Qin, X. (2019) · Scientific Reports
Bacterial Genetics and BiotechnologyEscherichia coli research studies
Cited by 8
- Verified
Inactivation of genes in oxidative respiration and iron acquisition pathways in pediatric clinical isolates of Small colony variant Enterobacteriaceae
Greninger, A. L., Addetia, A., Tao, Y., Adler, A., & Qin, X. (2021) · Scientific Reports
Bacterial Genetics and BiotechnologyEscherichia coli research studies
Cited by 8
- Verified
Endpoints and estimands: understanding trials of weight-loss drugs
Adler, A. I. (2022) · Nature Medicine
Statistical Methods in Clinical TrialsPharmacology and Obesity Treatment
Cited by 1
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free